darusentan?
Posted By: sm on 2009-03-25
In Reply to: BP being managed by the s/l *dariasentin* study (??) (nm) - jessme
Subject: darusentan?
Gilead is developing darusentan, a selective endothelin A (ETA) receptor antagonist, for the oral treatment of resistant hypertension
Complete Discussion Below: marks the location of current message within thread
The messages you are viewing
are archived/old. To view latest messages and participate in discussions, select
the boards given in left menu
Other related messages found in our database
|